12.01.09
Sabinsa Corporation, Piscataway, NJ, has received the 2009 Thomas Alva Edison Patent Award in the Nutraceuticals Category for the patent on its proprietary product, GarCitrin. The patent, U.S. #7063861, is titled “Bioavailable Composition of Natural and Synthetic HCA.” GarCitrin is a patented natural extract combining the weight management benefits of hydroxycitric acid (HCA) with the bioavailability-enhancing effects of garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica.